Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
06/27/2012 | CN102512548A Toxin-removing and fat-dispelling capsule |
06/27/2012 | CN102512532A Medicine composition for preventing and treating diseases of quail |
06/27/2012 | CN102512520A Normal-temperature preparation method for ultrafine powder hawthorn and special bilateral airflow sieving machine thereof |
06/27/2012 | CN102512495A Allergic cough oral liquid |
06/27/2012 | CN102512460A Combination of genistein, ganoderma lucidum spore powder and cordyceps mycelium |
06/27/2012 | CN102512459A Preparation method and use for pollution-free ganoderma lucidum ultrafine powder |
06/27/2012 | CN102512458A Semi-bionic extraction method for active components of Cordyceps militaris |
06/27/2012 | CN102512452A Process method for preparing sea cucumber glycosides by using sea cucumber coelomic fluid |
06/27/2012 | CN102512439A Ginseng oligosaccharide composition as well as preparation method and application thereof |
06/27/2012 | CN102512424A Compositions and methods relating to novel compounds and targets thereof |
06/27/2012 | CN102512410A Application of chlorogenic acid to preparing medicaments or foods for resisting against stress and prolonging life |
06/27/2012 | CN102512389A Fexofenadine hydrochloride oral disintegrating drug composition |
06/27/2012 | CN102512371A Preparation method for forsythiaside lipidosome |
06/27/2012 | CN102512368A Production technology of metallothionein flexible nano-liposomes |
06/27/2012 | CN102145061B Qidan nasal allergy medicament and preparation method thereof |
06/27/2012 | CN101972479B Preparation process of intravenous injection human immunoglobulin |
06/27/2012 | CN101926828B Method for extracting antibacterial substance, water soluble polysaccharide and chitin from blaps |
06/27/2012 | CN101912572B Multi-effect external plaster |
06/27/2012 | CN101850105B Cefuroxime sodium composite medicine |
06/27/2012 | CN101845385B Health-care wine and preparation method thereof |
06/27/2012 | CN101829162B Pharmaceutical composition for treating allergic rhinitis and preparation method thereof |
06/27/2012 | CN101804077B Pretreatment method of propolis effective component raw material by supercritical extraction |
06/27/2012 | CN101791332B Compound gingko health product solid preparation |
06/27/2012 | CN101773493B New application of medicine compound brazilein |
06/27/2012 | CN101632436B Fresh yam extract as well as preparation method and application thereof |
06/27/2012 | CN101628070B Chinese yam polysaccharides extract and preparation method and application thereof |
06/27/2012 | CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof |
06/27/2012 | CN101595096B Substituted carbinol compound |
06/27/2012 | CN101574464B Ageing-resisting and immunity-enhancing capsule prepared by multiple pure traditional Chinese drugs |
06/27/2012 | CN101564180B Walnut total nutriment and soft capsule and health products containing same |
06/27/2012 | CN101433329B Nutritive composition with health-care function |
06/27/2012 | CN101374950B Improved IL-15 and IL-15R-alpha for expression in mammalian cells |
06/27/2012 | CN101366831B Rhubarb polyoses, preparation method, medicament composition and uses |
06/27/2012 | CN101292688B Method for preparing folium phyllostachytis green tea effervescence piece |
06/27/2012 | CN101133790B Wilding synthesized five kinds of grain, pine nut compressed granules orange juice beverage and method of processing the same |
06/27/2012 | CN101133789B Wilding mineral composition corn, various grains, mountain wild fruits compressed granules and orange juice and method of processing the same |
06/27/2012 | CN101133787B Wilding synthesized black rice black soya bean compressed food granules beverage and method of processing the same |
06/26/2012 | USRE43497 Anti-MIF antibodies |
06/26/2012 | US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
06/26/2012 | US8207175 Inhibitor compounds |
06/26/2012 | US8206947 Human transmembrane proteins |
06/26/2012 | US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics |
06/26/2012 | US8206716 Methods of treating with anti-C5/C5a specific antibodies |
06/26/2012 | US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa |
06/26/2012 | US8206708 Vascular endothelial growth factor 2 |
06/26/2012 | CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor |
06/26/2012 | CA2566609C Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
06/26/2012 | CA2536185C Drug delivery system by administrating fine particles to sub-tenon |
06/26/2012 | CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases |
06/26/2012 | CA2445875C Pentapeptide compounds and uses related thereto |
06/26/2012 | CA2406853C Methods and compositions for eliciting an immune response |
06/26/2012 | CA2406225C Recombinant intracellular pathogen vaccines and methods for use |
06/21/2012 | WO2012082921A1 Cellular activation insulin therapy |
06/21/2012 | WO2012081692A1 Pyrazole derivative |
06/21/2012 | WO2012081650A1 Agent for alleviating delayed hypersensitivity |
06/21/2012 | WO2012080728A1 Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy |
06/21/2012 | WO2012080642A1 Use of an antibody directed against a membrane protein |
06/21/2012 | WO2012080500A1 Serum amyloid p protein |
06/21/2012 | WO2012080444A1 Method for suppressing an immune response |
06/21/2012 | WO2012080329A1 Formulations of n-(3,5-dichloropyridin-4-yl)-[1-(4-fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide |
06/21/2012 | WO2012080306A1 Cd89 activation in therapy |
06/21/2012 | WO2012079435A1 Scorpion active peptides and preparation methods and applications thereof |
06/21/2012 | WO2012079279A1 Pregnane glycoside compounds containing orthoester groups and use thereof |
06/21/2012 | WO2012055878A3 Method of treatment |
06/21/2012 | WO2012044090A3 Novel aminoquinazoline compound having a protein-kinase inhibiting action |
06/21/2012 | WO2011163600A3 Tacrolimus compositions for aerosol administration |
06/21/2012 | US20120159658 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
06/21/2012 | US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
06/21/2012 | US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis |
06/21/2012 | US20120157499 Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug |
06/21/2012 | US20120157470 Salts and crystalline forms of an apoptosis-inducing agent |
06/21/2012 | US20120157466 Heterocyclic compounds with cxcr3 antagonist activity |
06/21/2012 | US20120157443 Bruton's tyrosine kinase inhibitors |
06/21/2012 | US20120157442 Heteroaryl btk inhibitors |
06/21/2012 | US20120157437 Vla-4 inhibitory drug |
06/21/2012 | US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
06/21/2012 | US20120157429 Compounds useful as inhibitors of janus kinases |
06/21/2012 | US20120157428 Bromodomain inhibitors and uses thereof |
06/21/2012 | US20120157410 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
06/21/2012 | US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
06/21/2012 | US20120157396 Pyrazinamide for immunostimulation and the treatment of leishmaniases |
06/21/2012 | US20120157372 Human milk peptides |
06/21/2012 | US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells |
06/21/2012 | US20120156289 Biodegradable Osmotic Pump Implant For Drug Delivery |
06/21/2012 | US20120156287 Use of Vitelline Protein B as a Microencapsulating Additive |
06/21/2012 | US20120156282 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
06/21/2012 | US20120156281 Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein |
06/21/2012 | US20120156280 Myeloid derived suppressor cell inhibiting agents |
06/21/2012 | US20120156265 Conformable tissue repair implant capable of injection delivery |
06/21/2012 | US20120156258 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
06/21/2012 | US20120156251 Cationic oil-in-water emulsions |
06/21/2012 | US20120156247 Biocomposition stimulant of the immune system, anti-tumour and anti-hiv |
06/21/2012 | US20120156246 Reprogramming cancer cells |
06/21/2012 | US20120156244 Nasal Compositions and Uses Thereof |
06/21/2012 | US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody |
06/21/2012 | US20120156241 Rescue of influenza virus |
06/21/2012 | US20120156239 Optimized vaccines to provide protection against ebola and other viruses |
06/21/2012 | US20120156238 Herpes virus backbone for viral vaccine and vaccine based thereon |
06/21/2012 | US20120156236 Neisseria meningitidis antigens and compositions |
06/21/2012 | US20120156235 Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus |